Advanced search
Publication Cover
HIV Clinical Trials Volume 10, 2009 - Issue 3
Submit an article Journal homepage
50
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Longer Duration of HBV-Active Antiretroviral Therapy is Linked to Favorable Virological Outcome in HIV-HBV Co-infected Patients

Tsan LeeWake Forest University School of Medicine Winston Salem, North Carolina, USA
&
Marina NúñezDivision on Infectious Disease Department on Internal Medicine, Wake Forest University Health Sciences, Winston-Salem, North Carolina, USACorrespondence[email protected]
Pages 153-159 | Published online: 06 Jan 2015

REFERENCES

  • Nunez M, Soriano V. Management of patients co-infected with hepatitis B virus and HIV. Lancet Infect Dis. 2005;5:374–382.
  • Shire NJ, Sherman KE. Management of HBV/HIV-coinfected patients. Semin Liver Dis. 2005;25(Suppl 1):48–57.
  • Puoti M, Torti C, Bruno R, Filice G, Carosi G. Natural history of chronic hepatitis B in co-infected patients. J HepatoL 2006;44(1 Suppl):565–70.
  • Thio C, Locarnini S. Treatment of HIV/HBV co-infection: clinical and virological issues. AIDS Rev. 2007;9:40–53.
  • Nunez M, Belen R, Diaz-Pollan B, et al. Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy. AIDS Res Hum Retro virus. 2006;22:842–848.
  • Miailhes P, Trabaud MA, Pradat P, et al. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relation-ship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion. Clin Infect Dis. 2007;45:624–632.
  • Sheng WH, Kao JH, Chen PJ, et al. Evolution of hepatitis B serological markers in HIV-infected patients receiv-ing highly active antiretroviral therapy. Clin Infect Dis. 2007;45:1221–1229.
  • Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004;39(4)1147–1171.
  • Chu CJ, Keeffe EB, Han SH, et al. Hepatitis B virus geno-types in the United States: results of a nationwide study. Gastroenterology. 2003;125:444–451.
  • Bartlett JA. Addressing the challenges of adherence. J Acquir Immune Defic Syndr 2002; 29(Suppl 1):52–10.
  • Thio C, Seaberg E, Skolasky R, Phair J, Visscher B, Munoz A, Thomas DL, Multicenter AIDS Cohort Study. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter AIDS Cohort Study (MACS). Lancet. 2002;360:1921–1926.
  • Di Martino V, Thevenot T, Colin JF, et al. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology. 2002;123:1812–1822.
  • Bonacini M, Bzowej N, Louie S, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C. AIDS. 2004;18:2039–2045.
  • Sheng WH, Chen MY, Hsieh SM, et al. Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyper-endemic. Clin Infect Dis. 2004;38:1471–1477.
  • Konopnicki D, Mocroft A, de Wit S. Hepatitis B and HIV: prevalence, AIDS progression, response to HAART and increased mortality in the EuroSIDA cohort. AIDS. 2005;19:2117–2125.
  • Lascar RM, Lopes AR, Gilson RJ, et al. Effect of HIV infec-tion and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection. J Infect Dis. 2005;191:1169–1179.
  • Wursthorn K, Buggisch P, Lutgehetmann M, Zollner B, Petersen J. Temporary HBV resolution in an HIV-co-infected patient during HBV-directed combination therapy followed by relapse of HBV. Antivir Ther 2006;11:647–652.
  • Rouphael NG, Talati NJ, Rimland D. Hepatitis B reverse seroconversion in HIV-positive patients: case series and review of the literature. AIDS. 2007;21:771–774.
  • Brat N, Fox RK,Xiao P. Presentation and outcome of hepato-cellular carcinoma in HIV-infected patients: a US-Canadian multicenter study. J Hepatol. 2007;47:527–537.
  • Lloeje UH, Yang HI, Su J, et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. REVEAL-HBV Study Group. Gastroenterology. 2006;130:678–686.
  • Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507–539.
  • Bonacini M, Louie S, Bzowej N, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS. 2004;18(15):2039–2045.
  • Peters MG. Diagnosis and management of hepatitis B virus and HIV coinfection. Top HIV Med. 2007;15:163–166.
  • Sulkowski MS. Management of hepatic complications in HIV-infected persons. J Infect Dis. 2008;197(Suppl 3):S279—S293.
  • Soriano V, Puoti M, Peters M, et al. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS. 2008; 22:1399–1410.
  • Iser DM, Sasadeusz J. Current treatment of HIV/hep-atitis B virus coinfection. J Gastroenterol Hepatol. 2008;23:699–706.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.